Word

TAIHO ONCOLOGY

Status

Registered

Status Code

701

Status Date

Thursday, April 7, 2022

Serial Number

86235689

Registration Number

4710793

Registration Date

Tuesday, March 31, 2015

Mark Type

3000

Filing Date

Friday, March 28, 2014

Published for Opposition

Tuesday, January 13, 2015

Trademark Owner History

Taiho Pharmaceutical Co., Ltd. - Original Registrant

Classifications

5 Pharmaceutical preparations, namely, anti-cancer agents, anti-tumor agents, [ anti-ulcerogenic agents, agents for treatment of immunological diseases, agents for the treatment of urinary diseases, agents for pain, antiemetic agents, diagnostic agents, ] preparations and substances for medical purposes [, preparations for detecting genetic predispositions for medical purposes ]

44 Medical diagnostic testing in the fields of cancer, tumors [, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; providing medical information relating to the treatment or prevention of cancer, tumors [, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; medical consultation services relating to the treatment and diagnosis of cancer, tumors [, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; medical counseling services relating to the treatment of cancer, tumors [, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; genetic testing for medical purposes, namely, for the diagnosis and prognosis of the expected progression of cancer, tumors [, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; providing medical information relating to efficacy, side effects, and interactions of pharmaceuticals and medications; providing medical information

42 Scientific research for medical purposes in the field of cancer, tumors [, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain ] ; testing, inspection, research or evaluation of pharmaceuticals; [ advisory, consultancy or information services relating to testing, inspection, research or evaluation of pharmaceuticals and medicines; ] providing medical and scientific research information about the results of clinical trials for pharmaceutical products [ ; design and development of computer hardware and software for use in the field of medicine; research and development of medical technology ]

The mark consists of a white oval with a brown border, containing a brown "T"-shaped design below a yellow rounded rectangular shape and a smaller red rectangular shape within the oval, all above the wording "TAIHO" in brown stylized font and "ONCOLOGY" on a second line in black stylized font.
The color(s) brown, yellow, red, white and black is/are claimed as a feature of the mark.
The English translation of "TAIHO" in the mark is "big bird".
"ONCOLOGY"

Trademark Events

Mar 31, 2024

Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed

Apr 7, 2022

Notice Of Acceptance Of Sec. 8 - E-Mailed

Apr 7, 2022

Registered - Sec. 8 (6-Yr) Accepted

Mar 29, 2022

Case Assigned To Post Registration Paralegal

Sep 10, 2021

Teas Section 8 Received

Apr 5, 2017

Review Of Correspondence Complete - Address Updated

Jan 31, 2017

Correspondence Received In Law Office

Mar 31, 2015

Registered-Principal Register

Jan 13, 2015

Published For Opposition

Dec 24, 2014

Notice Of Publication

Dec 5, 2014

Law Office Publication Review Completed

Dec 1, 2014

Approved For Pub - Principal Register

Nov 25, 2014

Examiners Amendment Mailed

Nov 24, 2014

Examiner's Amendment Entered

Nov 24, 2014

Examiners Amendment -Written

Nov 20, 2014

Teas/Email Correspondence Entered

Nov 20, 2014

Correspondence Received In Law Office

Nov 19, 2014

Teas Response To Office Action Received

Jul 2, 2014

Priority Action Mailed

Jul 2, 2014

Priority Action Written

Jun 30, 2014

Assigned To Examiner

Apr 25, 2014

Preliminary/Voluntary Amendment - Entered

Apr 25, 2014

Assigned To Lie

Apr 12, 2014

Notice Of Design Search Code Mailed

Apr 11, 2014

New Application Office Supplied Data Entered

Apr 4, 2014

Teas Voluntary Amendment Received

Apr 1, 2014

New Application Entered